ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,011Medicare Part D Prescriptions Filled, Including Refills

Rank: 892 out of 3647

$550K Total Retail Price of All Prescriptions

Rank: 934 out of 3647

533 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 533 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 9,286 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 488 466 1 1
LEVOTHYROXINE SODIUM 402 381 2 5
OMEPRAZOLE 334 306 3 3
AMLODIPINE BESYLATE 317 310 4 2
METOPROLOL TARTRATE 304 277 5 7
LISINOPRIL 303 287 6 4
FUROSEMIDE 232 216 7 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 230 186 8 36
METFORMIN HCL 227 206 9 6
ATORVASTATIN CALCIUM 208 194 10 13
HYDROCHLOROTHIAZIDE 207 202 11 9
POTASSIUM CHLORIDE 191 179 12 24
HYDROCODONE-ACETAMINOPHEN 171 149 S3 13 12
CRESTOR 169 152 14 19
CARVEDILOL 162 154 15 20
TRANDOLAPRIL 158 158 16 441
PRAVASTATIN SODIUM 153 150 17 16
ZOLPIDEM TARTRATE 149 145 18 14
LOSARTAN POTASSIUM 137 121 19 11
CHLORTHALIDONE 128 127 20 208
SERTRALINE HCL 120 111 21 27
WARFARIN SODIUM 120 115 21 15
MELOXICAM 113 110 23 33
DIGOXIN 110 102 24 51
METOPROLOL SUCCINATE 110 94 24 18
DOXAZOSIN MESYLATE 109 104 26 57
SPIRONOLACTONE 98 94 27 77
ALENDRONATE SODIUM 96 94 28 23
INDAPAMIDE 95 95 29 296
ALLOPURINOL 92 91 30 37
GLIPIZIDE 91 75 31 41
PAROXETINE HCL 89 82 32 60
CITALOPRAM HBR 77 75 33 25
TRAMADOL HCL 75 41 34 22
ENALAPRIL MALEATE 74 73 35 35
ATENOLOL 69 65 36 10
ZETIA 69 69 36 96
LANTUS SOLOSTAR 68 60 38 124
DONEPEZIL HCL 64 64 39 30
FENOFIBRATE 63 60 40 50
GABAPENTIN 63 60 40 17
GLIPIZIDE ER 55 49 42 112
PANTOPRAZOLE SODIUM 53 41 43 38
ISOSORBIDE MONONITRATE ER 53 53 43 56
FOSINOPRIL SODIUM 53 53 43 241
KLOR-CON M20 53 53 43 121
DILTIAZEM ER 52 52 47 167
NEXIUM 51 51 48 44
KLOR-CON 10 51 51 48 106
CLOPIDOGREL 51 44 48 26
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.